Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... حسب Mengqing Yang (13253917)

الموضوعات:

Maximum concentrations (ng/L) of 88 pharmaceuticals detected at least once (in order of decreasing number of detections across all regions and samples) in water samples from wadeab... حسب Paul M. Bradley (523469)

JC-1 monomer increased with the stimulation of sFlt-1 and decreased after administration of Z-LEHD-FMK in HUVECs. حسب Yaling Zhai (9239458)

SLE decreases risk for hormonal cancers. حسب Deborah K. Johnson (10001156)

"…<p>Odds ratios (OR) and 95% confidence intervals of SLE and MS cohorts. For all graphs, the dotted line represents an OR of 1.0. …"

Comparison of mitochondrial respiration of HL-1 cells exposed to LG, NG, HG and IHG between short- (12h) and long-time (72h) glucose treatment. حسب Patrick Mordel (17020879)

Comparison of ATP production in HL-1 cells exposed to LG, NG, HG and IHG between short- (12h) and long-time (72h) glucose treatment. حسب Patrick Mordel (17020879)

Figure 5 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin حسب Joanna Domagala (21643925)

"…NK cells were primed with IL2 (200 U/mL) and IL15 (10 ng/mL) for 24 hours before the experiment. <b>G,</b> The level of perforin detected in NK cells incubated with NH₄Cl and other lysosomotropic agents [chloroquine (CQ), concanamycin (CMA), and monensin] for 4 hours determined by intracellular staining using antibodies detecting total perforin (B-D48 clone) and lysosomal perforin (δG9 clone; <i>n</i> = 2). …"

Knock-down of Atox1 in SW620 cells decreased cell migration and colony formation. حسب Arundhati Jana (157555)

Source data for Fig 1. حسب Rahsan Erdem (11726357)

الموضوعات:

Source data for Fig 2. حسب Rahsan Erdem (11726357)

الموضوعات:

Source data for Fig 3. حسب Rahsan Erdem (11726357)

الموضوعات:

Demographics and baseline characteristics of the safety population. حسب Rahsan Erdem (11726357)

الموضوعات:

Grading of stool consistency and diarrhea severity. حسب Rahsan Erdem (11726357)

الموضوعات:

Secondary efficacy endpoints for the modified intent-to-treat population. حسب Rahsan Erdem (11726357)

الموضوعات:

Source data for S1 and S2 Figs. حسب Rahsan Erdem (11726357)

الموضوعات:

Consolidated Standards for Reporting of Trials flow diagram. حسب Rahsan Erdem (11726357)

الموضوعات:

Diarrheal disease severity by treatment group for the modified intent-to-treat population. حسب Rahsan Erdem (11726357)

الموضوعات:

iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. حسب Rahsan Erdem (11726357)

الموضوعات:

Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. حسب Rahsan Erdem (11726357)

الموضوعات:

Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. حسب Rahsan Erdem (11726357)

الموضوعات: